Search Results

Displaying Results 1-1 of 1 "'ENTX'"

Apr 06, 2026, 13:50 ET Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners

Greenberg Traurig, P.A. advised Israel-based Entera Bio Ltd. (Nasdaq: ENTX), a clinical-stage biotechnology company focused on the development of oral peptide and protein replacement therapies, in a $10 million private placement

More news about: Greenberg Traurig, LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.